MHRA issues Conditional Marketing Authorisation for the COVID-19 Vaccine AstraZeneca in Great Britain
To date, supply of the AstraZeneca vaccine in the UK has been authorised on a temporary basis by the MHRA under Regulation 174 of the Human Medicine Regulations 2012. A Summary of Product Information, Patient Information Leaflet and Conditions of Authorisation have been issued.
Source:
Medicines and Healthcare products Regulatory Agency
SPS commentary:
Updated versions of the Information for healthcare professionals and Information for UK recipients documents are also now available from the MHRA website.